Literature DB >> 35663119

Synthesis of Agelastatin A and Derivatives Premised on a Hidden Symmetry Element Leading to Analogs Displaying Anticancer Activity.

Haoran Xue1,2, Haleigh Svatek2,3, Ariane F Bertonha1, Keighley Reisenauer2,3, Joshua Robinson1,2, Minwoo Kim1,2, Alec Ingros2,3, Matthew Ho1,2, Joseph Taube3, Daniel Romo1.   

Abstract

Entities:  

Year:  2021        PMID： 35663119      PMCID： PMC9165445          DOI： 10.1016/j.tet.2021.132340

Source DB:  PubMed          Journal:  Tetrahedron        ISSN： 0040-4020            Impact factor:   2.388


× No keyword cloud information.
  35 in total

1.  A stereoselective synthesis of the bromopyrrole natural product (-)-agelastatin A.

Authors:  Paul M Wehn; J Du Bois
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

2.  Synthesis of a highly functionalized core of verrillin.

Authors:  Alec Saitman; Emmanuel A Theodorakis
Journal:  Org Lett       Date:  2013-04-30       Impact factor: 6.005

3.  Bioinspired total synthesis of agelastatin A.

Authors:  Jeremy Chris P Reyes; Daniel Romo
Journal:  Angew Chem Int Ed Engl       Date:  2012-06-11       Impact factor: 15.336

Review 4.  Biosynthesis, asymmetric synthesis, and pharmacology, including cellular targets, of the pyrrole-2-aminoimidazole marine alkaloids.

Authors:  Ali Al-Mourabit; Manuel A Zancanella; Supriya Tilvi; Daniel Romo
Journal:  Nat Prod Rep       Date:  2011-05-09       Impact factor: 13.423

5.  New class of nucleophiles for palladium-catalyzed asymmetric allylic alkylation. Total synthesis of agelastatin A.

Authors:  Barry M Trost; Guangbin Dong
Journal:  J Am Chem Soc       Date:  2006-05-10       Impact factor: 15.419

6.  Asymmetric total synthesis of (-)-agelastatin a using sulfinimine (N-sulfinyl imine) derived methodologies.

Authors:  Franklin A Davis; Jianghe Deng
Journal:  Org Lett       Date:  2005-02-17       Impact factor: 6.005

7.  Agelastatin A: a novel inhibitor of osteopontin-mediated adhesion, invasion, and colony formation.

Authors:  Charlene K Mason; Suzanne McFarlane; Patrick G Johnston; Paul Crowe; Pauline J Erwin; Mathias M Domostoj; F Charles Campbell; Soraya Manaviazar; Karl J Hale; Mohamed El-Tanani
Journal:  Mol Cancer Ther       Date:  2008-03       Impact factor: 6.261

8.  Total synthesis of the beta-catenin inhibitor, (-)-agelastatin A: a second-generation approach based on radical aminobromination.

Authors:  Takehiko Yoshimitsu; Tatsunori Ino; Naoyuki Futamura; Takuma Kamon; Tetsuaki Tanaka
Journal:  Org Lett       Date:  2009-08-06       Impact factor: 6.005

9.  Inhibition of Eukaryotic Translation by the Antitumor Natural Product Agelastatin A.

Authors:  Brandon McClary; Boris Zinshteyn; Mélanie Meyer; Morgan Jouanneau; Simone Pellegrino; Gulnara Yusupova; Anthony Schuller; Jeremy Chris P Reyes; Junyan Lu; Zufeng Guo; Safiat Ayinde; Cheng Luo; Yongjun Dang; Daniel Romo; Marat Yusupov; Rachel Green; Jun O Liu
Journal:  Cell Chem Biol       Date:  2017-04-27       Impact factor: 8.116

Review 10.  A submarine journey: the pyrrole-imidazole alkaloids.

Authors:  Barbara Forte; Beatrice Malgesini; Claudia Piutti; Francesca Quartieri; Alessandra Scolaro; Gianluca Papeo
Journal:  Mar Drugs       Date:  2009-11-27       Impact factor: 5.118
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.